OnKure Therapeutics, Inc.（OKUR）内部人交易：高管与董事近期交易
过去 18 个月，共有 13 位内部人为 OnKure Therapeutics, Inc.（OKUR）报告了 36 笔 Form 4 交易（最近一笔 2026-09-23）。
| 日期 | 内部人 | 职务 | 类型 | 股数 | 市值 |
|---|---|---|---|---|---|
| 2026-09-23 | Leverone Jason A. | Chief Financial Officer | 卖出 | 302 | $898 |
| 2026-09-23 | Saccomano Nicholas A | President and CEO | 卖出 | 87 | $259 |
| 2026-06-24 | Saccomano Nicholas A | President and CEO | 卖出 | 86 | $378 |
| 2026-06-24 | Leverone Jason A. | Chief Financial Officer | 卖出 | 303 | $1,333 |
| 2026-03-24 | Leverone Jason A. | Chief Financial Officer | 卖出 | 301 | $1,252 |
| 2026-03-24 | Saccomano Nicholas A | President and CEO | 卖出 | 86 | $358 |
| 2026-01-02 | Mathers Edward T | 董事 | 买入 | 3,911 | $0 |
| 2026-01-02 | Manke Isaac | 董事 | 买入 | 5,258 | $0 |
| 2025-12-23 | Saccomano Nicholas A | President and CEO | 卖出 | 87 | $258 |
| 2025-12-23 | Leverone Jason A. | Chief Financial Officer | 卖出 | 302 | $897 |
| 2025-10-02 | Mathers Edward T | 董事 | 买入 | 4,125 | $0 |
| 2025-10-02 | Manke Isaac | 董事 | 买入 | 5,545 | $0 |
| 2025-09-24 | Leverone Jason A. | Chief Financial Officer | 卖出 | 303 | $794 |
| 2025-09-24 | Saccomano Nicholas A | President and CEO | 卖出 | 88 | $231 |
| 2025-07-02 | Manke Isaac | 董事 | 买入 | 6,311 | $0 |
| 2025-07-02 | Mathers Edward T | 董事 | 买入 | 4,694 | $0 |
| 2025-06-25 | Leverone Jason A. | Chief Financial Officer | 卖出 | 303 | $721 |
| 2025-06-25 | Saccomano Nicholas A | President and CEO | 卖出 | 88 | $209 |
| 2025-05-19 | Hove Anders D | 10% 以上股东 | 买入 | 270,270 | $500,000 |
| 2025-05-19 | Chen Bihua | 内部人 | 卖出 | 1.8M | $3.4M |
| 2025-05-19 | Cormorant Global Healthcare Master Fund, LP | 内部人 | 卖出 | 1.8M | $3.4M |
| 2025-05-19 | Cormorant Private Healthcare Fund III LP | 内部人 | 卖出 | 1.8M | $3.4M |
| 2025-05-19 | Cormorant Private Healthcare Fund IV LP | 内部人 | 卖出 | 1.8M | $3.4M |
| 2025-05-19 | Cormorant Private Healthcare Fund V LP | 内部人 | 卖出 | 1.8M | $3.4M |
| 2025-05-19 | Cormorant Asset Management, LP | 内部人 | 卖出 | 1.8M | $3.4M |
来源：SEC Form 4 申报文件 · 截至 2026-09-23